NasdaqCM:CLPTMedical Equipment
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses
ClearPoint Neuro (CLPT) just posted its FY 2025 numbers with Q4 revenue of US$10.4 million, a basic EPS loss of US$0.27, and trailing twelve month revenue of US$37.0 million alongside a trailing EPS loss of US$0.90. Over recent periods, the company has seen quarterly revenue move from US$7.8 million in Q4 2024 to US$10.4 million in Q4 2025, while quarterly EPS losses shifted from US$0.20 to US$0.27 over the same stretch. For investors, the update sets solid top line progress against ongoing...